- Home
- PK vs CERT Comparison
PK vs CERT Comparison
Compare PK & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PK
- CERT
- Stock Information
- Founded
- PK 1946
- CERT 2008
- Country
- PK United States
- CERT United States
- Employees
- PK N/A
- CERT N/A
- Industry
- PK Real Estate Investment Trusts
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- PK Real Estate
- CERT Technology
- Exchange
- PK Nasdaq
- CERT Nasdaq
- Market Cap
- PK 2.5B
- CERT 2.3B
- IPO Year
- PK N/A
- CERT 2020
- Fundamental
- Price
- PK $10.06
- CERT $11.16
- Analyst Decision
- PK Hold
- CERT Buy
- Analyst Count
- PK 9
- CERT 6
- Target Price
- PK $13.44
- CERT $15.60
- AVG Volume (30 Days)
- PK 4.6M
- CERT 1.7M
- Earning Date
- PK 05-05-2025
- CERT 05-05-2025
- Dividend Yield
- PK 9.65%
- CERT N/A
- EPS Growth
- PK 45.67
- CERT N/A
- EPS
- PK 0.61
- CERT N/A
- Revenue
- PK $2,602,000,000.00
- CERT $394,498,000.00
- Revenue This Year
- PK $2.68
- CERT $11.47
- Revenue Next Year
- PK $3.32
- CERT $9.03
- P/E Ratio
- PK $17.00
- CERT N/A
- Revenue Growth
- PK N/A
- CERT 9.37
- 52 Week Low
- PK $8.27
- CERT $8.64
- 52 Week High
- PK $16.23
- CERT $17.76
- Technical
- Relative Strength Index (RSI)
- PK 43.17
- CERT 40.34
- Support Level
- PK $9.98
- CERT $11.15
- Resistance Level
- PK $10.60
- CERT $11.75
- Average True Range (ATR)
- PK 0.26
- CERT 0.39
- MACD
- PK -0.05
- CERT -0.06
- Stochastic Oscillator
- PK 5.98
- CERT 17.83
About PK Park Hotels & Resorts Inc.
Park Hotels & Resorts owns upper-upscale and luxury hotels with 22,711 rooms across 37 hotels in the United States. Park also has interests through joint ventures in another 2,271 rooms in three US hotels. Park was spun out of narrow-moat Hilton Worldwide Holdings at the start of 2017, so most of the company's hotels are still under Hilton brands. The company has sold all its international hotels and many of its lower-quality US hotels to focus on high-quality assets in domestic gateway markets.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.